Evidence map›Paper›PMID 40993220›Full record

ArticleBone marrow transplantation2025

Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients.

Davide Leardini, Marcello Roberto, Sara Roggiani, Edoardo Muratore, Marco Fabbrini, Gianluca Storci, Enrica Tomassini, Elisa Dan, Angela Schipani, Serena De Matteis and 7 more

Abstract read
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Davide Leardini *Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Marcello Roberto *IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Sara RoggianiHuman Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. sara.roggiani3@unibo.it.ORCID 0009-0008-2455-6624
Edoardo MuratorePediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Marco FabbriniHuman Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.ORCID 0000-0003-1431-0643
Gianluca StorciIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Enrica TomassiniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Elisa DanIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Angela SchipaniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Serena De MatteisIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Barbara SinigagliaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Daria MesselodiIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Nicola Salvatore BertuccioIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Arcangelo PretePediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Patrizia BrigidiHuman Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Francesca BonifaziIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0003-1544-9911
Riccardo MasettiPediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) profoundly reshapes the gut microbiome (GM), yet age-related differences in this process remain incompletely understood. In this study, we analyzed stool samples from a cohort of pediatric and adult patients collected before allo-HSCT and at neutrophil engraftment to assess GM dynamics. We observed a significant reduction in alpha diversity post-HSCT across both age groups, with young patients displaying notably lower biodiversity. While GM composition varies among age ranges before transplantation, these distinctions largely disappeared at neutrophil engraftment, indicating a convergence toward a more uniform "transplant-specific" signature. This shift entailed a loss of health-associated, butyrate-producing taxa and a rise in potentially opportunistic bacteria (e.g., Enterococcaceae, Staphylococcaceae). Low pre-allo-HSCT GM diversity correlated with an increased risk of clinically significant acute graft-versus-host disease, overwhelming the age differences, underscoring the clinical relevance of maintaining a balanced microbiome before transplantation. Overall, our findings highlight the importance of age in shaping the pre-transplant GM and reveal how allo-HSCT-driven factors homogenize microbial communities among age ranges, offering insights for future microbiome-targeted interventions to improve transplant outcomes.

Indexed as

Gastrointestinal MicrobiomeHematopoietic Stem Cell TransplantationAdolescentAdultAge FactorsChildChild, PreschoolFemaleGraft vs Host DiseaseHumansInfantMaleMiddle AgedYoung Adult

Identifiers

PMID40993220
PMCPMC12672365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.